Urokinase-type Plasminogen Activator Resulting from Endometrial Carcinogenesis Enhances Tumor Invasion and Correlates with Poor Outcome of Endometrial Carcinoma Patients

Chia-Yen Huang , Ming-Cheng Chang, Wei Yun Huang, Ching-Ting Huang, Yu-Chien Tang, Hsien-Da Huang, Kuan-Ting Kuo, Chi-An Chen, Wen-Fang Cheng

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

The purpose of this study was to identify the dysregulated genes involved in the tumorigenesis and progression of endometrial endometrioid adenocarcinoma (EEC), and their possible mechanisms. Endometrial specimens including normal endometrial tissues, atypical endometrial hyperplasia, and EEC were analyzed. The expression profiles were compared using GeneChip Array. The gene expression levels were determined by real-time RT-PCR in the training and testing sets to correlate the clinico-pathological parameters of EEC. Immunoblotting, in vitro cell migration and invasion assays were performed in human endometrial cancer cell lines and their transfectants. In microarray analysis, seven dysregulated genes were identified. Only the levels of urokinase-type plasminogen activator (uPA) were higher in EEC with deep myometrial invasion, positive lympho-vascular space invasion, lymph node metastasis, and advanced stages. After multivariate analysis, uPA was the only independent poor prognostic factor for disease-free survival in the EEC patients (hazard ratio: 4.65, p - 0.03). uPA may enhance the migratory and invasive capabilities of endometrial tumor cells by the phosphorylation of ERK1/2, Akt and p38 molecules. uPA is a dysregulated gene involved in the tumorigenesis, bio-pathological features and outcomes of EEC. uPA may be a potential molecule and target for the detection and treatment of EEC.
Original languageEnglish
JournalScientific Reports
Volume5
DOIs
StatePublished - 2 Jan 2015

Keywords

  • CANCER CELL INVASION; INHIBITOR TYPE-1; PROSTATE-CANCER; BREAST-CANCER; PROGNOSTIC-SIGNIFICANCE; MOLECULAR PATHOLOGY; LYSYL HYDROXYLASE; JNK PATHWAYS; IN-VIVO; EXPRESSION

Fingerprint Dive into the research topics of 'Urokinase-type Plasminogen Activator Resulting from Endometrial Carcinogenesis Enhances Tumor Invasion and Correlates with Poor Outcome of Endometrial Carcinoma Patients'. Together they form a unique fingerprint.

  • Cite this